$0.87
0.02 (+1.84%)
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX)
CAPS Rating:
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.